Chinese Herbs for Diabetes Prevention; Long-Term Tepezza Data; Novel Cushing's Tx News and commentary from the endocrinology world Jun 03, 2024
Novel Drug Reduces Steroid Need in Congenital Adrenal Hyperplasia No nonglucocorticoid treatments currently approved for this rare disorder Jun 02, 2024
Finally, a Treatment Emerges for Autoimmune Polyendocrine Syndrome And it's on the pharmacy shelf now May 29, 2024
How Many Ditch GLP-1 Drugs? More Weekly Insulin Data; Ozempic for Alcohol Use? News and commentary from the endocrinology world May 28, 2024
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma May 25, 2024 podcast
Ultra-Processed Foods and Mortality; Improving Cardiovascular Risk Assessment Also in TTHealthWatch: low testosterone in men and mortality May 18, 2024 podcast
Yet Another Benefit for Metformin? Study suggests a surprising effect in rheumatologic disease risk May 17, 2024
Obesity Mystery Solved: The Reversible Cause You Never Knew Can you guess what caused this patient's extreme weight gain? May 16, 2024
Wegovy Perks Sustained for Years; Most Have 'CKM Syndrome'; New Adrenal Guidelines News and commentary from the endocrinology world May 14, 2024
Low Testosterone Linked With Mortality Risk in Aging Men Meta-analysis examined studies with mass spectroscopy measures, providing greater accuracy May 13, 2024
Study Offers Clues on Asthma Control for Patients With Concurrent Diabetes Compared with metformin, some newer diabetes agents linked with more acute exacerbations May 10, 2024
Teprotumumab Improves Thyroid Eye Disease Across Phenotypes Both younger and older patients had similar overall improvements May 10, 2024
Ozempic Price Cut; Hypoparathyroidism Tx Fast Tracked; Halle Berry's Menopause Bill News and commentary from the endocrinology world May 07, 2024
Hypothalamic Obesity Tx; Weekly Insulin Under Review; Ozempic Price Investigation News and commentary from the endocrinology world Apr 30, 2024
New T2D Guidelines; More Cushing's Relacorilant Data; Drug Shortages Rage On News and commentary from the endocrinology world Apr 23, 2024
Tirzepatide Improves Sleep Apnea in Patients With Obesity, Drugmaker Says Topline results add yet another potential reason for use of dual GIP/GLP-1 receptor agonist Apr 18, 2024
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs? News and commentary from the endocrinology world Apr 16, 2024
No Link Between GLP-1 Drugs and Suicide, Says European Regulator EMA announcement comes a few months after FDA's preliminary evaluation Apr 12, 2024
Cass Review Finds Weak Evidence for Puberty Blockers, Hormones in Youth Gender Care Review leader Hilary Cass, MD, says medical treatment for gender is "built on shaky foundations" Apr 10, 2024
Biden Admin Imposes National Limits on 'Forever Chemicals' in Drinking Water Most important action the EPA has ever taken on PFAS, says agency administrator Apr 10, 2024
Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithm News and commentary from the endocrinology world Apr 09, 2024
Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes? News and commentary from the endocrinology world Apr 02, 2024
Here's What OTC Continuous Glucose Monitors Can Do for Our Patients FDA's approval may be a step toward greater access Mar 30, 2024
Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? News and commentary from the endocrinology world Mar 26, 2024
Telehealth Sites Promise Cure for 'Male Menopause' Despite FDA Ban on Off-Label Ads Websites make big promises, experts urge caution Mar 24, 2024
Medicare to Cover Weight-Loss Drug Wegovy for Certain Patients News comes in the wake of FDA approval to reduce risk of heart attacks, stroke Mar 21, 2024
Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures? News and commentary from the endocrinology world Mar 19, 2024
Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woes News and commentary from the endocrinology world Mar 12, 2024
Obesity Drugs Like Wegovy Are Meant for Long-Term Use, but Some Want to Stop Other patients have been forced to ration or halt doses due to drug costs Mar 08, 2024
Semaglutide Reduced Inflammatory Biomarkers in HIV Patients With Lipohypertrophy Levels of IL-6, high-sensitivity CRP, and soluble CD163 were decreased with the GLP-1 agonist Mar 06, 2024
Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D News and commentary from the endocrinology world Mar 05, 2024
Biden's Physical Results; Weight Loss Implant Tested; Richard Lewis Dies Health news and commentary from around the Web gathered by ΒιΆΉ΄«Γ½ staff Feb 29, 2024
FDA Announces End to 'Forever Chemicals' in U.S. Food Packaging PFAS chemicals have been tied to a number of health issues Feb 28, 2024
Amy Schumer's Diagnosis; FDA Yanks Cancer Drug; Nursing Student Murdered Health news and commentary from around the Web gathered by ΒιΆΉ΄«Γ½ staff Feb 26, 2024
T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals News and commentary from the endocrinology world Feb 20, 2024
Surgical Remission of Cushing's Disease Tied to New Autoimmune Conditions But glucocorticoid replacement right after surgery may be protective Feb 19, 2024
More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Risk News and commentary from the endocrinology world Feb 06, 2024
Tirzepatide's Association With BP Reduction Reinforced With ABPM Data Combination GLP-1/GIP receptor agonist is currently approved for T2D and weight loss Feb 05, 2024
Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supply News and commentary from the endocrinology world Jan 30, 2024
Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism Daily treatment substantially reduced hypoglycemia over 13 weeks Jan 24, 2024